New research has revealed that removing a protein called gasdermin D can protect the liver from inflammation and scarring in ...

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted regulatory approval for a label expansion of KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) in a combination ...

A breakthrough study reveals how nanoparticles can transport anti-inflammatory drugs past the blood-brain barrier, offering ...

Rocket Pharmaceuticals' gene therapies offer long-term effects for cardiovascular and hematology diseases. Read why I rate ...

When the UCLA team gave Cilengitide to mice with low type 5 collagen, it slowed down the scarring and kidney damage.

Post Liberation Day, life science companies are clarifying the likely impact of Trump's tariffs – and the news is largely positive.

Cysts, fibrosis, and tubular degeneration form the typical triad of pathologies leading to the gradual decline in kidney ...

Researchers have identified type 5 collagen as a key factor in kidney fibrosis, revealing its potential as a biomarker to predict chronic kidney disease progression. A repurposed anti-cancer drug, ...

New UCLA research conducted using mouse models and human genetic data has uncovered a critical factor that determines how ...

New UCLA research conducted using mouse models and human genetic data has uncovered a critical factor that determines how much scarring occurs following kidney injury, leading scientists to identify a ...

Liver fibrosis is the build up of scar tissue in the liver when it tries to heal itself. Symptoms may include fatigue, ...